The biological consequence of obesity on the kidney

Nephrology Dialysis Transplantation

Volumn 28, Issue SUPPL.4, 2013, Pages

  Kanasaki, Keizo ^a   Kitada, Munehiro ^a   Kanasaki, Megumi ^a   Koya, Daisuke ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Focal segmental glomerulosclerosis; Low birthweight; Obesity; Proteinuria

Indexed keywords

DISEASE ASSOCIATION; DYSLIPIDEMIA; FOCAL GLOMERULOSCLEROSIS; GLOMERULOMEGALY; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLEPTINEMIA; HYPERTENSION; INCIDENCE; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY HYPERTROPHY; NONHUMAN; OBESITY; OBESITY RELATED GLOMERULOPATHY; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLEEP DISORDERED BREATHING; WEIGHT REDUCTION;

FOCAL SEGMENTAL GLOMERULOSCLEROSIS; LOW BIRTHWEIGHT; OBESITY; PROTEINURIA;

ANIMALS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INFANT, LOW BIRTH WEIGHT; KIDNEY; OBESITY;

EID: 84890096942     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft098     Document Type: Review

References (49)

1. Kanasaki K, Koya D. Biology of obesity: lessons from animal models of obesity. J Biomed Biotech 2011; 2011: 197636
2. Preble W. Obesity observations on one thousand cases. Boston Med Surg J 1923; 188: 618-621
3. Weisinger JR, Kempson RL, Eldridge FL et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974; 81: 440-447
4. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509
5. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008; 294: F685-F696
6. Praga M, Hernandez E, Morales E et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001; 16: 1790-1798
7. Chen HM, Li SJ, Chen HP et al. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis 2008; 52: 58-65
8. Tsuboi N, Koike K, Hirano K et al. Clinical features and longterm renal outcomes of Japanese patients with obesity-related glomerulopathy. Clin Exp Nephrol 2012; in press.
9. Kasiske BL, Napier J. Glomerular sclerosis in patients with massive obesity. Am J Nephrol 1985; 5: 45-50
10. Chen HM, Liu ZH, Zeng CH et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 2006; 48: 772-779
11. Praga M. Synergy of low nephron number and obesity: a newfocus on hyperfiltration nephropathy. Nephrol Dial Transplant 2005; 20: 2594-2597
12. Krauss RM,Winston M, Fletcher BJ et al. Obesity: impact on cardiovascular disease. Circulation 1998; 98: 1472-1476
13. Hall JE, Henegar JR, Dwyer TM et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 2004; 11: 41-54
14. Bidani AK, Griffin KA. Long-term renal consequences of hypertension for normal and diseased kidneys. Curr Opin Nephrol Hypertens 2002; 11: 73-80
15. Henegar JR, Bigler SA, Henegar LK et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001; 12: 1211-1217
16. Chagnac A, Weinstein T, Korzets A et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278: F817-F822
17. Chagnac A, Herman M, Zingerman B et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 2008; 23: 3946-3952
18. Kanasaki M, Nagai T, Kitada M et al. Elevation of the anti-fibrotic peptide N-acetyl-eryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors. Fibrogenesis Tissue Repair 2011; 4: 25
19. Grone EF,Walli AK, Grone HJ et al. The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 1994; 107: 1-13
20. Stenvinkel P, Alvestrand A, Angelin B et al. LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion. Eur J Clin Invest 2000; 30: 866-870
21. Kasiske BL, O'Donnell MP, Cleary MP et al. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988; 33: 667-672
22. Jiang T,Wang Z, Proctor G et al. Diet-induced obesity in C57BL/ 6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein- 1c-dependent pathway. J Biol Chem 2005; 280: 32317-32325
23. Chen HM, Zheng CX, Gao Q et al. Heart-type fatty acid binding protein is ssociated with proteinuria in obesity. PLoS One 2012; 7: e45691
24. Wilson C, Nelson R, Nicolson M et al. Plasma leptin concentrations: no difference between diabetic Pima Indians with and without nephropathy. Diabetologia 1998; 41: 861-862
25. Tesauro M, Mascali A, Franzese O et al. Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin. Int J Hypertens 2012; 2012: 943605
26. Wolf G, Hamann A, Han DC et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]. Kidney Int 1999; 56: 860-872
27. Ichimura K, Kawashima Y, Nakamura T et al. Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy. Biochem Biophys Res Commun 2013; 431: 712-717.
28. Praga M, Hernandez E, Andres A et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995; 70: 35-41
29. Shen WW, Chen HM, Chen H et al. Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol 2010; 5: 1401-1409
30. Afshinnia F, Wilt TJ, Duval S et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010; 25: 1173-1183
31. Sklar AH, Chaudhary BA. Reversible proteinuria in obstructive sleep apnea syndrome. Arch Intern Med 1988; 148: 87-89
32. Casserly LF, Chow N, Ali S et al. Proteinuria in obstructive sleep apnea. Kidney Int 2001; 60: 1484-1489
33. Serra A, Romero R, Lopez D et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008; 73: 947-955
34. Daskalopoulou EG, Liavvas C, Nakas CT et al. Obstructive sleep apnoea syndrome promotes reversal albuminuria during sleep. Sleep Breath 2011; 15: 589-597
35. Novick AC, Gephardt G, Guz B et al. Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 1991; 325: 1058-1062
36. Foster MH, Sant GR, Donohoe JF et al. Prolonged survival with a remnant kidney. Am J Kidney Dis 1991; 17: 261-265
37. Fine LG, Woolf AS, Gallego C. Of rats and men: the need for more convincing clinical studies on progression of renal diseases. Am J Kidney Dis 1991; 17: 258-260
38. Kiprov DD, Colvin RB, McCluskey RT. Focal and segmental glomerulosclerosis and porteinuria associated with unilateral renal agenesis. Lab Invest 1982; 46: 275-281
39. Gonzalez E, Gutierrez E, Morales E et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int 2005; 68: 263-270
40. Vickers MH, Breier BH, Cutfield WS et al. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000; 279: E83-E87
41. Barker DJ, Forsen T, Eriksson JG et al. Growth and living conditions in childhood and hypertension in adult life: a longitudinalstudy. J Hypertens 2002; 20: 1951-1956
42. Pope DP, Mishra V, Thompson L et al. Risk of low birth weight and stillbirth associated with indoor air pollution from solid fuel use in developing countries. Epidemiol Rev 2010; 32: 70-81
43. Ejerblad E, Fored CM, Lindblad P et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702
44. Kawada T, Miyata S, Shimada T et al. A study of cardiovascularfunction in Tsumura Suzuki obese diabetes, a new model mouse of type 2 diabetes. Biol Pharm Bull 2010; 33: 998-1003
45. Coimbra TM, Janssen U, Grone HJ et al. Early events leading to renal injury in obese Zucker (fatty) rats with type 2 diabetes. Kidney Int 2000; 57: 167-182
46. Uriu K, Kaizu K, Qie YL et al. Renal hemodynamics in Otsuka Long-Evans Tokushima atty rat, a model rat of spontaneous non-insulin-dependent diabetes mellitus with obesity. J Lab Clin Med 1999; 134: 483-491
47. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007; 125: 451-472
48. Speakman J, Hambly C, Mitchell S et al. Animal models ofobesity. Obes Rev 2007; 8(Suppl 1): 55-61
49. Clee SM, Attie AD. The genetic landscape of type 2 diabetes in mice. Endocr Rev 2007; 28: 48-83